| Product Code: ETC6665345 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Canada Psoriasis Therapeutics Market Overview |
3.1 Canada Country Macro Economic Indicators |
3.2 Canada Psoriasis Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Canada Psoriasis Therapeutics Market - Industry Life Cycle |
3.4 Canada Psoriasis Therapeutics Market - Porter's Five Forces |
3.5 Canada Psoriasis Therapeutics Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Canada Psoriasis Therapeutics Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
4 Canada Psoriasis Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of psoriasis in Canada |
4.2.2 Growing awareness and diagnosis rates for psoriasis |
4.2.3 Advancements in research and development of new psoriasis treatments |
4.3 Market Restraints |
4.3.1 High cost associated with psoriasis therapeutics |
4.3.2 Stringent regulatory requirements for approval of new treatments |
4.3.3 Side effects and risks associated with existing psoriasis medications |
5 Canada Psoriasis Therapeutics Market Trends |
6 Canada Psoriasis Therapeutics Market, By Types |
6.1 Canada Psoriasis Therapeutics Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Canada Psoriasis Therapeutics Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Canada Psoriasis Therapeutics Market Revenues & Volume, By Plaque Psoriasis, 2021- 2031F |
6.1.4 Canada Psoriasis Therapeutics Market Revenues & Volume, By Psoriatic Arthritis, 2021- 2031F |
6.2 Canada Psoriasis Therapeutics Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Canada Psoriasis Therapeutics Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.3 Canada Psoriasis Therapeutics Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.2.4 Canada Psoriasis Therapeutics Market Revenues & Volume, By Topical, 2021- 2031F |
7 Canada Psoriasis Therapeutics Market Import-Export Trade Statistics |
7.1 Canada Psoriasis Therapeutics Market Export to Major Countries |
7.2 Canada Psoriasis Therapeutics Market Imports from Major Countries |
8 Canada Psoriasis Therapeutics Market Key Performance Indicators |
8.1 Patient adherence rate to prescribed psoriasis treatments |
8.2 Number of clinical trials and research studies conducted in the field of psoriasis therapeutics |
8.3 Rate of adoption of novel treatment modalities in the management of psoriasis |
9 Canada Psoriasis Therapeutics Market - Opportunity Assessment |
9.1 Canada Psoriasis Therapeutics Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Canada Psoriasis Therapeutics Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
10 Canada Psoriasis Therapeutics Market - Competitive Landscape |
10.1 Canada Psoriasis Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 Canada Psoriasis Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |